Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation

This publication has 56 references indexed in Scilit:

• Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
  The Lancet, 2008
• Zotarolimus-Eluting Stents in Patients with Native Coronary Artery Disease: Clinical and Angiographic Outcomes in 1,317 Patients
  The American Journal of Cardiology, 2007
• Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement
  Circulation, 2006
• Two-Year-Plus Follow-Up of a Paclitaxel-Eluting Stent in De Novo Coronary Narrowings (TAXUS I)
  The American Journal of Cardiology, 2005
• External validity of randomised controlled trials: “To whom do the results of this trial apply?”
  The Lancet, 2005
• Late stent thrombosis after implantation of a sirolimus‐eluting stent
  Catheterization and Cardiovascular Interventions, 2003
• Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
  New England Journal of Medicine, 2003
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trials
  Blood Pressure, 1992
• Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
  Journal of the American College of Cardiology, 1988